COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,157 Articles (22,703 medRxiv, 8,454 bioRxiv)

Most recent first Previous |  Page 1680: Articles 16791-16800  | Next

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers
Riahi, S., Lee, J. H., Wei, S., Cost, R., Masiero, A., Prades, C., Olfati-Saber, R., Wendt, M., Park, A., Qiu, Y., Zhou, Y.
10.1101/2021.03.23.436613 — Posted: 2021-03-23
Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody domains
Sun, Z., Kim, A., Sobolewski, M. D., Enick, N., Chen, C., Adams, C., Jacobs, J. L., McCormick, K. D., Mellors, J. W., Dimitrov, D. S., Li, W.
10.1101/2021.03.22.436481 — Posted: 2021-03-23
Dry Swab Method of sample collection for SARS-CoV2 testing can be used for culturing virus
Ram, S., Enayathullah, M. G., Parekh, Y., Tallapaka, K. B., Mishra, R. K., Kiran Kumar, B.
10.1101/2021.03.23.436593 — Posted: 2021-03-23
Characterization and functional interrogation of SARS-CoV-2 RNA interactome
Labeau, A., Lefevre-Utile, A., Bonnet-Madin, L., Fery-Simonian, L., Soumelis, V., Lotteau, V., Vidalain, P.-O., Amara, A., Meertens, L.
10.1101/2021.03.23.436611 — Posted: 2021-03-23
The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice
Rice, A., Verma, M., Shin, A., Zakin, L., Sieling, P., Tanaka, S., Balint, J., Dinkins, K., Adisetiyo, H., Morimoto, B., Taft, J., Patel, R. S., Buta, S., Martin-Fernandez, M., Bogunovic, D., Spilman, P. R., Gabitzsch, E. R., Safrit, J. T., Rabizadeh, S., Niazi, K., Soon-Shiong, P.
10.1101/2021.03.22.436476 — Posted: 2021-03-23
Protein-primed RNA synthesis in SARS-CoVs and structural basis for inhibition by AT-527
Shannon, A., Fattorini, V., Sama, B., Selisko, B., Feracci, M., Falcou, C., Gauffre, P., El Kazzi, P., Decroly, E., Rabah, N., Toulon, K., Eydoux, C., Guillemot, J.-C., Noel, M., Debart, F., Vasseur, J.-J., Moussa, A., Good, S., Lin, K., Sommadossi, J.-P., Zhu, Y., Yan, X., Shi, H., Ferron, F., Canard, B.
10.1101/2021.03.23.436564 — Posted: 2021-03-23
Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New York
Lesho, E., Corey, B., Lebreton, F., Ong, A., Swierczewski, B., Bennett, J., Walsh, E., McGann, P.
10.1101/2021.03.11.21253231 — Posted: 2021-03-23 Discussion: Offsite
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection
Sandoval, D. R., Mandel Clausen, T., Nora, C., Magida, J. A., Cribbs, A. P., Denardo, A., Clark, A. E., Garretson, A. F., Coker, J. K. C., Narayanan, A., Majowicz, S. A., Philpott, M., Johansson, C., Dunford, J. E., Spliid, C. B., Golden, G. J., Payne, N. C., Tye, M. A., Nowell, C. J., Griffis, E. R., Piermatteo, A., Grunddal, K. V., Alle, T., Hauser, B. M., Feldman, J., Caradonna, T. M., Pu, Y., Yin, X., McVicar, R. N., Kwong, E. M., Tsimikas, S., Schmidt, A. G., Ballatore, C., Zengler, K., Chanda, S. K., Weiss, R. J., Downes, M., Evans, R. M., Croker, B. A., Leibel, S. L., Jose, J., Mazitschek, R., Oppermann, U., Esko, J. D., Carlin, A. F., Gordts, P. L. S. M.
10.1101/2021.03.22.436522 — Posted: 2021-03-23
Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro
Fred, M. S., Kuivanen, S., Ugurlu, H., Cabrera Casarotto, P., Levanov, L., Saksela, K., Vapalahti, O., Castren, E.
10.1101/2021.03.22.436379 — Posted: 2021-03-23
Age-related changes in the upper respiratory microbiome are associated with SARS-CoV-2 susceptibility and illness severity
Hurst, J. H., McCumber, A. W., Aquino, J. N., Rodriguez, J., Heston, S. M., Lugo, D. J., Rotta, A. T., Turner, N. A., Pfeiffer, T. S., Gurley, T. C., Moody, M. A., Denny, T. N., Rawls, J. F., Woods, C. W., Kelly, M. S.
10.1101/2021.03.20.21252680 — Posted: 2021-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).